Your browser doesn't support javascript.
loading
Guidelines for Clinical Management of Premenstrual Syndrome
Article in Ko | WPRIM | ID: wpr-71307
Responsible library: WPRO
ABSTRACT
Premenstrual syndrome(PMS) refers to a group of menstruation-related symptoms that impair daily activity and interpersonal relationship. The therapeutic modality for PMS consists of non-pharmacologic and pharmacologic treatment. Generally, after confirmation of PMS, a set of non-pharmacologic treatments is recommended before pharmacologic treatment. Patients can be benefited from non-pharmacological treatments such as patient education, cognitive therapy, behavioral therapy, and dietary supplementation. Pharmacologic therapy including psychotropic agents, diuretics, and prostaglandin inhibitors may be used, when PMS symptoms are not sufficiently improved after non-pharmacologic treatments, or when symptoms fit the diagnostic criteria of premenstrual dysphoric disorder(PMDD). When treatment fails, hormonal therapy to manipulate menstrual cycle may be considered, and several trials showed improvement of physical and mood symptoms.
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Prostaglandin Antagonists / Premenstrual Syndrome / Cognitive Behavioral Therapy / Patient Education as Topic / Dietary Supplements / Diuretics / Menstrual Cycle Type of study: Guideline Limits: Female / Humans Language: Ko Journal: Journal of the Korean Medical Association Year: 2005 Type: Article
Full text: 1 Index: WPRIM Main subject: Prostaglandin Antagonists / Premenstrual Syndrome / Cognitive Behavioral Therapy / Patient Education as Topic / Dietary Supplements / Diuretics / Menstrual Cycle Type of study: Guideline Limits: Female / Humans Language: Ko Journal: Journal of the Korean Medical Association Year: 2005 Type: Article